f.h. investments, inc. (dba asteria health)drugHigh PriorityActive

ESTRADIOL Contamination Recall

ESTRADIOL,15 mg, Pellet, Asteria Health 432 Industrial Ln has been recalled due to presence of foreign substance - potential presence of metal particulate matter. This recall primarily affects healthcare providers and hospitals. Individual consumers are unlikely to have this product.

By RecallRadar Editorial Team

Sourced from FDA. Last verified March 4, 2026.

On this page

Free checker

Check if you qualify

See whether your device may qualify for a free repair or replacement program before you spend money.

Check if you qualify

Key facts

Date announced
January 26, 2026
Source agency
FDA

This recall involves safety concerns. Take action promptly.

Plain-English Summary

ESTRADIOL,15 mg, Pellet, Asteria Health 432 Industrial Ln has been recalled due to presence of foreign substance - potential presence of metal particulate matter. This recall primarily affects healthcare providers and hospitals. Individual consumers are unlikely to have this product.

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

What's Being Recalled

Quoted source excerpt from the official notice.

Presence of Foreign substance - potential presence of metal particulate matter

Quick Info

Key facts from the official notice, kept in the article flow for easy cross-checking.

Brand
F.h. investments, inc. (dba asteria health)
Category
drug
Source agency
FDA
Announced
January 26, 2026
Country
US
Status
Active

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot#: 253000118, Exp. 02/21/2026; 253000145, Exp. 08/02/2026; 253000146, Exp. 06/30/2026, 253000167, Exp. 09/23/2026.

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

What You Should Do

Follow the remedy path from the official notice using the exact model and serial details above.

  1. 1## ESTRADIOL,15 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3015-
  2. 2Agency: FDA | Category: drug Reason: Presence of Foreign substance - potential presence of metal particulate matter What to do:
  3. 3Stop using the product if your lot/model matches.
  4. 4Check the FDA notice for specifics.
Open Official Recall Notice

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source
FDA
Announced by source
January 26, 2026
Last reviewed by RecallRadar
March 4, 2026

Frequently Asked Questions

Am I affected by this recall?

Check the affected models section on this page. The official notice currently lists Lot#: 253000118, Exp. 02/21/2026; 253000145, Exp. 08/02/2026; 253000146, Exp. 06/30/2026, 253000167, Exp. 09/23/2026..

What is the remedy for this recall?

## ESTRADIOL,15 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3015-32. Agency: FDA | Category: drug Reason: Presence of Foreign substance - potential presence of metal particulate matter What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: f.h. investments, inc. (dba asteria health) recall hub and Food & Drug recall hub.

Official Resources

Use these primary sources for final eligibility and claim instructions.

View official notice from FDA

See an inaccuracy?

Help us improve the accuracy of this recall information.

500 characters remaining

Related Recalls

Liraglutide
High PriorityActive

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.

Presence of particulate matter: a white thread-like structure in the cartridge

May 27, 2026

Erythromycin
High PriorityActive

Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3).

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

May 27, 2026

Integradose compounding services llc
High PriorityActive

fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.

Subpotent Drug

May 27, 2026

Atomoxetine
High PriorityActive

Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01

Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.

May 27, 2026

Primidone
High PriorityActive

Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-637-05

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

May 27, 2026